{"brief_title": "Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)", "brief_summary": "This study is an open label, noncomparative study using an investigational agent for the treatment of documented Candida or Aspergillus infections in pediatric patients (ages 3 months-17 years).", "condition": "Candidiasis", "intervention_type": "Drug", "intervention_name": "caspofungin acetate", "description": "Duration of Treatment - 7-90 days", "other_name": "MK0991", "criteria": "- Children, 3 months through 17 years of age, - with esophageal candidiasis or - invasive candidiasis or - children requiring salvage treatment of invasive aspergillosis.", "gender": "All", "minimum_age": "3 Months", "maximum_age": "17 Years", "healthy_volunteers": "No", "id": "NCT00082524.xml"}